Laure-Alix Clerbaux

7PUBLICATIONS
20CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Bioavailability and ecotoxicologyCentral nervous systemAgricultural molecular engineering of nucleic acids and proteinsNatural products and bioactive compounds
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 10, 2024
An overview of immune safety avatar: mimicking the effects of immunomodulatory therapies on the immune system.

Vanessa Neuhaus, Laure-Alix Clerbaux, Katherina Sewald

|Apr 11, 2024
Evaluation of the ecological risk of pesticide residues from the European LUCAS Soil monitoring 2018 survey.

Antonio Franco, Diana Vieira, Laure-Alix Clerbaux

|Nov 11, 2022
The Adverse Outcome Pathway Framework Applied to Neurological Symptoms of COVID-19.

Helena T Hogberg, Ann Lam, Elan Ohayon

|Oct 14, 2022
Gut as an Alternative Entry Route for SARS-CoV-2: Current Evidence and Uncertainties of Productive Enteric Infection in COVID-19.

Laure-Alix Clerbaux, Sally A Mayasich, Amalia Muñoz

|Oct 14, 2022
Mechanistic Understanding of the Olfactory Neuroepithelium Involvement Leading to Short-Term Anosmia in COVID-19 Using the Adverse Outcome Pathway Framework.

Muhammad Ali Shahbaz, Francesca De Bernardi, Arto Alatalo

|Sep 23, 2022
Mechanisms Leading to Gut Dysbiosis in COVID-19: Current Evidence and Uncertainties Based on Adverse Outcome Pathways.

Laure-Alix Clerbaux, Julija Fillipovska, Amalia Muñoz

Pageof 2

Frequent Collaborators

3 joint publications

Lucia Grenga

3 joint publications

Mauro Petrillo

2 joint publications

Maria Cristina Albertini

2 joint publications

Sandra Coecke